One of the major concerns about growing human embryonic stem cells in the lab to generate tissues for medical therapies can now be laid to rest, suggest the results of a new study. Among the safety fears of using human embryonic stem cells (hESCs) for therapies was that the process of “imprinting” - the switching off and on of genes during development - might be changed by growing the cells in culture rather than in the uterus.